ROLE OF M-CSF IN THE PATHOGENESIS OF ATHEROSCLEROSIS

M-CSF 在动脉粥样硬化发病机制中的作用

基本信息

项目摘要

Macrophage(MO)-colony stimulating factor (M-CSF) importantly contributes to the development of atherosclerotic lesions. We have found that the absence of M-CSF in atherosclerosis-prone apolipoprotein (apo) E or low-density lipoprotein receptor (LDLR)- deficient mice results in substantially reduced atherosclerosis despite augmented hypercholesterolemia. Our most recent studies provide compelling evidence in favor of a direct local effect of M-CSF within the vessel wall. These advances, together with the characterization of the M-CSF-mediated induction of urokinase plasminogen activator (uPA) and matrix metalloproteinases (MMPs) cascade have prompted more refined questions on the molecular mechanisms responsible for the full range of M-CSF actions in the diseased vessel wall. In this proposal, we seek to extend our research efforts to understand the role of M-CSF in the development and disruption of arterial lesions by testing following three hypotheses: 1) pleiotropic effects of M-CSF on intimal MO and SMC are modulated mainly through the activation of nuclear factors downstream to the Ras-mediated cell signaling pathways. One such factor is the transcription factor Ets-2 that promotes cell proliferation and survival, 2) increased M-CSF activity in atherosclerotic lesions contributes to the MO -mediated matrix remodeling by up regulating the expression of uPA and MT3-MMP genes. This effect of M-CSF may play a role in plaque disruption, and 3) M-CSF up regulates the MO-specific transcription of uPA and MT3-MMP genes by activating a common set of trans-acting factors (such as Ets family of transcription factors) that form ternary complexes with AP-l and bind to cis-acting DNA elements present in the 5' regulatory region of these genes. The specific aims are: 1) to investigate the effects of M-CSF on the growth of arterial lesion-associated cells in vivo using mice lacking M-CSF and/or apoE and to perform in vitro studies using cultured cells from M-CSF-deficient mice to determine the mechanism(s) underlying the M-CSF mediated proliferation and survival of MO and SMC, 2) to determine the effects of M-CSF on the expression of uPA and MT3-MMP in cultured MO and to examine the association of M-CSF regulated production of uPA and MT3-MMP to alterations in the character of atherosclerotic lesions, and 3) to identify the cis-acting elements in the uPA and MT3-MMP promoters that mediate the inductive effects of M-CSF on the expression of these genes and to examine the signaling events connecting M-CSF with the nuclear regulators of uPA and MT3-MMP. We believe our studies will provide new and important information regarding the role of M-CSF in the development and disruption of atherosclerotic and proliferative vascular lesions and this information may prove useful in design of novel therapeutic interventions for vascular diseases.
巨噬细胞(MO)集落刺激因子(M-CSF)

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of macrophage colony-stimulating factor in the development of neointimal thickening following arterial injury.
巨噬细胞集落刺激因子在动脉损伤后新内膜增厚发展中的作用。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tripathi Byasmuni Rajavashisth其他文献

Tripathi Byasmuni Rajavashisth的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tripathi Byasmuni Rajavashisth', 18)}}的其他基金

M-CSF ISOFORMS IN ATHEROSCLEROSIS
动脉粥样硬化中的 M-CSF 亚型
  • 批准号:
    2692327
  • 财政年份:
    1998
  • 资助金额:
    $ 30.6万
  • 项目类别:
M-CSF ISOFORMS IN ATHEROSCLEROSIS
动脉粥样硬化中的 M-CSF 异构体
  • 批准号:
    6030830
  • 财政年份:
    1998
  • 资助金额:
    $ 30.6万
  • 项目类别:
M-CSF ISOFORMS IN ATHEROSCLEROSIS
动脉粥样硬化中的 M-CSF 亚型
  • 批准号:
    6389692
  • 财政年份:
    1998
  • 资助金额:
    $ 30.6万
  • 项目类别:
M-CSF ISOFORMS IN ATHEROSCLEROSIS
动脉粥样硬化中的 M-CSF 异构体
  • 批准号:
    6184012
  • 财政年份:
    1998
  • 资助金额:
    $ 30.6万
  • 项目类别:
M CSF AND THE PATHOGENESIS OF ATHEROSCLEROSIS
M CSF 与动脉粥样硬化的发病机制
  • 批准号:
    2609329
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:
ROLE OF M-CSF IN THE PATHOGENESIS OF ATHEROSCLEROSIS
M-CSF 在动脉粥样硬化发病机制中的作用
  • 批准号:
    6476934
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:
M CSF AND THE PATHOGENESIS OF ATHEROSCLEROSIS
M CSF 与动脉粥样硬化的发病机制
  • 批准号:
    2229051
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:
ROLE OF M-CSF IN THE PATHOGENESIS OF ATHEROSCLEROSIS
M-CSF 在动脉粥样硬化发病机制中的作用
  • 批准号:
    6625308
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:
M CSF AND THE PATHOGENESIS OF ATHEROSCLEROSIS
M CSF 与动脉粥样硬化的发病机制
  • 批准号:
    2029081
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:
ROLE OF M-CSF IN THE PATHOGENESIS OF ATHEROSCLEROSIS
M-CSF 在动脉粥样硬化发病机制中的作用
  • 批准号:
    6287020
  • 财政年份:
    1994
  • 资助金额:
    $ 30.6万
  • 项目类别:

相似国自然基金

卡路里限制的T细胞糖脂代谢重塑机制及网络调控
  • 批准号:
    91957111
  • 批准年份:
    2019
  • 资助金额:
    80.0 万元
  • 项目类别:
    重大研究计划
高尿酸血症促进动脉粥样硬化机制探讨
  • 批准号:
    81170251
  • 批准年份:
    2011
  • 资助金额:
    14.0 万元
  • 项目类别:
    面上项目
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
  • 批准号:
    81070247
  • 批准年份:
    2010
  • 资助金额:
    33.0 万元
  • 项目类别:
    面上项目
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
  • 批准号:
    81000086
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
  • 批准号:
    30971216
  • 批准年份:
    2009
  • 资助金额:
    31.0 万元
  • 项目类别:
    面上项目
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
  • 批准号:
    30871040
  • 批准年份:
    2008
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目

相似海外基金

Identifying the Role of Sex Hormones in Carotid Atherosclerotic Plaque Instability
确定性激素在颈动脉粥样硬化斑块不稳定中的作用
  • 批准号:
    494557
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Operating Grants
Smooth muscle cell-derived cell fates and cellular interactions in atherosclerotic plaque stability in disease progression and regression.
平滑肌细胞衍生的细胞命运和细胞相互作用在疾病进展和消退中动脉粥样硬化斑块的稳定性。
  • 批准号:
    10567844
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk
鉴定导致动脉粥样硬化斑块稳定性和心血管疾病风险的平滑肌细胞基因
  • 批准号:
    10720225
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
Endothelial Cell Respiration in Atherosclerotic Plaque Erosion
动脉粥样硬化斑块糜烂中的内皮细胞呼吸
  • 批准号:
    10586227
  • 财政年份:
    2023
  • 资助金额:
    $ 30.6万
  • 项目类别:
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression
研究 2019 年冠状病毒病 (COVID-19) 感染是否加速动脉粥样硬化斑块进展的机制登记
  • 批准号:
    10482402
  • 财政年份:
    2022
  • 资助金额:
    $ 30.6万
  • 项目类别:
Carotid Atherosclerotic Plaque Instability: what's sex got to do with it?
颈动脉粥样硬化斑块不稳定:性别与它有什么关系?
  • 批准号:
    455156
  • 财政年份:
    2021
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Fellowship Programs
Role of Smooth Muscle-derived Vascular Progenitor Cells (AdvSca1-SM) in Vasa Vasorum Expansion and Atherosclerotic Plaque Progression
平滑肌源性血管祖细胞 (AdvSca1-SM) 在血管滋养管扩张和动脉粥样硬化斑块进展中的作用
  • 批准号:
    10686163
  • 财政年份:
    2021
  • 资助金额:
    $ 30.6万
  • 项目类别:
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) alters atherosclerotic plaque progression
研究 2019 年冠状病毒病 (COVID-19) 感染是否会改变动脉粥样硬化斑块进展的机制登记
  • 批准号:
    10280423
  • 财政年份:
    2021
  • 资助金额:
    $ 30.6万
  • 项目类别:
Role of Smooth Muscle-derived Vascular Progenitor Cells (AdvSca1-SM) in Vasa Vasorum Expansion and Atherosclerotic Plaque Progression
平滑肌源性血管祖细胞 (AdvSca1-SM) 在血管滋养管扩张和动脉粥样硬化斑块进展中的作用
  • 批准号:
    10582515
  • 财政年份:
    2021
  • 资助金额:
    $ 30.6万
  • 项目类别:
Determining the role of endothelial activation on microRNA communication in atherosclerotic plaque: towards identifying of a novel therapeutic target in carotid disease
确定内皮激活对动脉粥样硬化斑块中 microRNA 通讯的作用:确定颈动脉疾病的新治疗靶点
  • 批准号:
    416180
  • 财政年份:
    2019
  • 资助金额:
    $ 30.6万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了